Please use this identifier to cite or link to this item:
|Title:||Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia||Authors:||Takeuchi, S.
|Issue Date:||Oct-2011||Citation:||Takeuchi, S., Matsushita, M., Zimmermann, M., Ikezoe, T., Komatsu, N., Seriu, T., Schrappe, M., Bartram, C.R., Koeffler, H.P. (2011-10). Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia. Leukemia Research 35 (10) : 1345-1349. ScholarBank@NUS Repository. https://doi.org/10.1016/j.leukres.2011.04.015||Abstract:||Methylation profile was analyzed in ninety-five patients with childhood acute lymphoblastic leukemia (ALL). Methylation of both MGMT and p16 genes were associated with higher age (p = 0.01 and p = 0.03, respectively). Methylation of both p15 and SHP1 genes occurred more frequently in T-ALL than in precursor B-ALL (p = 0.02 and p = 0.01, respectively). In contrast, methylation of the DAPK gene was more frequent in precursor B-ALL (p = 0.01). Patients with methylation of multiple genes more likely had T cell phenotype, and are classified as medium/high risk (p = 0.004 and p = 0.03, respectively). These results suggest that methylation status is associated with clinicopathological features in childhood ALL. © 2011 Elsevier Ltd.||Source Title:||Leukemia Research||URI:||http://scholarbank.nus.edu.sg/handle/10635/125371||ISSN:||01452126||DOI:||10.1016/j.leukres.2011.04.015|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.